SCHEMBL26259342

SCHEMBL26259342

CC(C)(C)c1ccc2ccccc2c1-c1cccs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.41
ALDH1A1 P00352 8/20 0.39
KDM4E B2RXH2 6/20 0.39
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPT P10636 7/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
BLM P54132 1/20 0.38
RPS6KB2 Q9UBS0 1/20 0.37
KCNJ11 Q14654 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ADORA2A P29274 1/20 0.36
LMNA P02545 4/20 0.35
GAA P10253 4/20 0.35
HPGD P15428 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALOX5 P09917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26259681 0.84 ALDH1A1 (0.40) ACHEALDH1A1KDM4ERAB9ANPC1
SCHEMBL26259368 0.82 NR1I2 (0.45) ACHEALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL1906196 0.80 HSD17B10 (0.48) ALDH1A1KDM4ERAB9AHSD17B10MAPT
SCHEMBL26259657 0.79 ACHE (0.37) ACHEALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL26259245 0.78 CYP2A6 (0.47) ACHEALDH1A1KDM4ERAB9ANPC1
SCHEMBL26259521 0.77 ACHE (0.41) ACHEALDH1A1KDM4ERAB9ANPC1
SCHEMBL9422234 0.76 ALDH1A1 (0.43) ACHEALDH1A1KDM4ERAB9ANPC1
SCHEMBL28486816 0.75 ALDH1A1 (0.42) ACHEALDH1A1KDM4ERAB9ANPC1
SCHEMBL16694238 0.74 KDM4E (0.42) ACHEALDH1A1KDM4ERAB9ANPC1
SCHEMBL26259279 0.74 MAPT (0.66) ACHEALDH1A1KDM4ERAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 ACHE 1754/4885ALDH1A1 2125/4885KDM4E 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.